Research and Development
Zika causes microcephaly and other birth defects, says CDC
April 14, 2016 Medical Communications, Research and Development CDC, Zika, Zika virus, birth defects, microcephaly
Merck says its Zepatier showed better efficacy and safety compared with competition in Phase III trials
April 14, 2016 Research and Development, Sales and Marketing Gilead, HCV, Merck & Co, Zepatier
AbbVie announces positive Phase III results in hepatitis C drug
April 14, 2016 Manufacturing and Production, Research and Development AbbVie, hepatitis, phase III
Sanofi reinforces collaboration with Stevenage Bioscience Catalyst with partnering office
April 13, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, Stevenage Bioscience Catalyst, academia, industry, partnership, pharma, stevenage
Bristol-Myers Squibb cancer immunotherapy Opdivo approved in EU
April 13, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, EU, NICE, approval, immunotherapy, opdivo
US FDA committee recommends against fast-track approval of Clovis’ cancer drug, asks for more data
April 13, 2016 Medical Communications, Research and Development
Structure of Zika virus revealed in new study
April 13, 2016 Research and Development NIH, Purdue, Zika, glycoprotein, structure
FDA accepts biologics license application for MSD’s allergy immunotherapy drug
April 13, 2016 Research and Development, Sales and Marketing MSD, Merck, allergy, dust mite, house, immunotherapy, mk-8237
Boehringer Ingelheim’s Giotrif significantly lowers lung cancer progression in Phase II trials
April 13, 2016 Research and Development AstraZeneca, Boehringer Ingelheim, Iressa, giotrif, lung cancer
Valeant bondholders issue notice to default
April 13, 2016 Research and Development, Sales and Marketing Valeant, bondholders, default, fears, possibility
Focus: Ovarian cancer and the case of elusive cure
April 12, 2016 Research and Development J&J, JJ, Pfizer, drug trials, ovarian cancer
EUSA Pharma acquires global rights to oncology support drug
April 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Eusa Pharma, acroral, acroral tab, global rights, oncology
Regeneron agrees six-year $75 million upfront licencing deal with Intellia for gene technology
April 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing IPO, Intellia Therapeutics, Licencing, Regeneron Pharmaceuticals, crispr, deal, gene editing, genetics
Clinical studies point to consistent efficacy in AstraZeneca’s treatment for drug-resistance bacteria
April 12, 2016 Manufacturing and Production, Research and Development AstraZeneca, avibactam, ceftazidime, gram resistant
Roche’s Venclexta gets accelerated approval from US FDA for chronic lymphocytic leukemia
April 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Roche, US FDA, Venclexta, chronic lymphocytic leukemia
